Omega MonoPure 1300 EC Interactions
There are 76 drugs known to interact with Omega MonoPure 1300 EC (omega-3 polyunsaturated fatty acids), along with 2 disease interactions. Of the total drug interactions, 76 are moderate.
- View all 76 medications that may interact with Omega MonoPure 1300 EC
- View Omega MonoPure 1300 EC disease interactions (2)
Most frequently checked interactions
View interaction reports for Omega MonoPure 1300 EC (omega-3 polyunsaturated fatty acids) and the medicines listed below.
- acetylcysteine
- Adderall XR (amphetamine / dextroamphetamine)
- Allegra (fexofenadine)
- alpha-lipoic acid
- alprazolam
- amlodipine
- arnica topical
- Aspir 81 (aspirin)
- Ativan (lorazepam)
- Blisovi Fe 1 / 20 (ethinyl estradiol / norethindrone)
- Boniva (ibandronate)
- bupropion
- carvedilol
- Centrum Silver Women's (multivitamin with minerals)
- Centrum Singles-Beta Carotene (beta-carotene)
- cephalexin
- cetirizine
- chondroitin / glucosamine
- Claritin (loratadine)
- clobetasol topical
- copper glycinate/zinc glycinate
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- DayQuil / NyQuil Severe Cold and Flu (acetaminophen / dextromethorphan / doxylamine / guaifenesin / phenylephrine)
- diltiazem
- Lexapro (escitalopram)
- loratadine
- losartan
- spironolactone
- turmeric
Omega MonoPure 1300 EC disease interactions
There are 2 disease interactions with Omega MonoPure 1300 EC (omega-3 polyunsaturated fatty acids) which include:
Report options
QR code containing a link to this page
More about Omega MonoPure 1300 EC (omega-3 polyunsaturated fatty acids)
- Omega MonoPure 1300 EC consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.